Cejka Cejka D D Cardiovascular safety of anti-sclerostin therapy in chronic kidney disease Cardiovascular safety of anti-sclerostin therapy in chronic kidney disease Metabolites Metabolites 2021 2021 11 11 11 11 770 770 10.3390/metabo11110770 10.3390/metabo11110770 supplied-pmid 34822428? This evidence concerns the gene SOST and chronic kidney disease.